Bioquell PLC Statement re Purchase of Own Shares (4504Z)
March 14 2017 - 10:17AM
UK Regulatory
TIDMBQE
RNS Number : 4504Z
Bioquell PLC
14 March 2017
RNS announcement 14(th) March 2017
Bioquell PLC
("Bioquell", or "the Company")
Purchase of own shares
Further to the Company's announcement on 13 March 2017 stating
its intention to reduce its capital by means of purchasing its
shares from time to time using existing cash resources, the Company
announces that on 13 March 2017 it purchased 25,000 of its ordinary
shares on the London Stock Exchange at a price of 135 pence per
share. The purchased shares will all be held as treasury
shares.
Total Number of Voting Rights
The issued share capital of the Company is comprised of
22,944,780 ordinary shares of 10p each. As 632,000 of these
ordinary shares are held as treasury shares, the total number of
voting rights in the Company is 22,312,780. This figure may be used
by shareholders as the denominator for the calculations by which
they will determine if they are required to notify their interest
in, or a change to their interest in, the Company under the FCA's
Disclosure Guidance and Transparency Rules.
Enquiries:
Bioquell PLC Tel: +44 (0)1264
835800
Ian Johnson, Executive Chairman
Michael Roller, Finance
Director
N+1 Singer Tel: +44 (0) 20
7496 3000
Mark Taylor
This information is provided by RNS
The company news service from the London Stock Exchange
END
STRMMGMFDDKGNZM
(END) Dow Jones Newswires
March 14, 2017 10:17 ET (14:17 GMT)
Bioquell (LSE:BQE)
Historical Stock Chart
From Feb 2024 to Mar 2024
Bioquell (LSE:BQE)
Historical Stock Chart
From Mar 2023 to Mar 2024